Connect with us

Hi, what are you looking for?

Jewish Business News

Leadership

Laura And Isaac Perlmutter Establish A $50 Million Fund To Advance Cancer Research And Treatment At NYU’s Langone Medical Center

The Perlmutters are  long-time supporters of the medical center’s cancer programs.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.

Isaac "Ike" Perlmutter

New York University’s  have recently  announced that they have been recipients or a gift of more $50 million, partly from Laura and Isaac Perlmutter personally as well as from the  Laura and Isaac Perlmutter Foundation Inc, which will  be used by the center  to advance cancer research and treatment.

In recognition of the Perlmutters’  ongoing support, New York University has taken the step of renaming the Langone center, which is designated as a  National Cancer Institute. The center will now be known as the Laura and Isaac Perlmutter Cancer Center at NYU Langone.

Announcing details of the Perlmutter’s generous endowment and the decision to remame the center in their honor, Robert I. Grossman, MD, the current  dean and CEO OF NYU Langone stated that for  the past three decades Laurie and Ike have been a constant source of support for  our programs, and always in a manner of  generosity and foresight. Thank’s to their most  recent gift the Medical Center’s already world-class cancer care, research, and education programs to become truly integrated across all disciplines, regardless of their physical locations within our growing care network.

Their gift ensures that all facilities embraced by the new Perlmutter Cancer Center will have a dynamic infrastructure in place to strengthen the bridges between our scientists and clinicians.  “The naming of the Perlmutter Cancer Center is a tribute to our Super Hero supporters for their tireless efforts on behalf of our institution.” Dr Grossman summed up.

 

The Perlmutters’ most recent  gift, will enable even greater program coordination, foster new synergies, and unite cancer research, patient care, and education around the singular focus of producing better outcomes for patients, as well as providing the Perlmutter Cancer Center with the facilities to attract and retain the services of  nationally recognized physicians and research scientists.

In addition the Center will be given more tools to enhance  progress in cancer research, diagnosis and treatment, as well as the education of the next generation of clinical and scientific leaders at NYU School of Medicine.

Dafna Bar-Sagi, PhD, senior vice president and vice dean for science, as well as chief scientific officer at NYU School of Medicine echoed Dr, Grossman’s remarks  by adding that the medical profession is  now at a moment in history when there are great opportunities to make bold advances in cancer research.

“ At the same time, , the research community as a whole is facing extreme challenges, with having to contend with plunging national research budget cuts.  “ As a result of the Perlmutter’s generosity the center  will be able  to continue focusing  on the prevention and treatment of cancer and realize the full potential of the extraordinary research that goes on at NYU Langone.” Dr. Bar Sagi  explained.

 

Mrs. Laura Perlmutter has been a member of the NYU Langone community for more than 30 years, initially as a volunteer in the hospital’s gift shop, later rising to become  president of the Tisch Hospital Auxiliary, a position she held for seven years,  from 1985 to 1992, as well as sitting on the board of trustees  for NYU Langone from the same year. Laura Perlmutter has sat on the  Cancer Advisory Board since 2005.

Isaac Perlmutter was also  recently seconded on to the board of trustees for the NYU Langone Cancer Center.

 

Isaac “Ike” Perlmutter  was born in Mandatory Palestine. After serving in the Israeli army during the Six-Day War of 1967, Perlmutter  emigrated to the United States, settling in New York, where, through a combination of  hard work, determination, and innate business skills which characterized him throughout his working life,  either established  or acquired a number of business ventures. Among the companies that Isaac Perlmutter has owned are  Remington Products and Marvel Toys, while today Perlmutter acts as CEO  of Marvel Entertainment, a position he has held  since January 2005, remaining with the company after it was fully acquired  by The Walt Disney Company on the end of December 2009.

 

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.